Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 2;35(6):469-474.
doi: 10.1055/s-0042-1758138. eCollection 2022 Nov.

Management of Anastomotic Leaks in Ileal Pouch Anal Anastomosis for Ulcerative Colitis

Affiliations
Review

Management of Anastomotic Leaks in Ileal Pouch Anal Anastomosis for Ulcerative Colitis

Alex Liu Huang et al. Clin Colon Rectal Surg. .

Abstract

Anastomotic leaks remain a dreaded complication after ileal pouch anal anastomosis (IPAA). Their impacts can be devastating, ranging from an acute leak leading to postoperative sepsis to chronic leaks and sinus tracts resulting in long-term pouch dysfunction and subsequent pouch failure. The management of acute leaks is intricate. Initial management is important to resolve acute sepsis, but the type of acute intervention impacts long-term pouch function. Aggressive management in the postoperative period, including the use of IV fluids, broad-spectrum antibiotics, and operative interventions may be necessary to preserve pouch structure and function. Early identification and knowledge of the most common areas of leak, such as at the IPAA anastomosis, are important for guiding management. Long-term complications, such as pouch sinuses, pouch-vaginal fistulas, and diminished IPAA function complicate the overall survival and functionality of the pouch. Knowledge and awareness of the identification and management of leaks is crucial for optimizing IPAA success.

Keywords: Crohn's of the pouch; anastomotic leak; ileal pouch anal anastomosis; pouch-vaginal fistula.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None declared.

References

    1. Kosaraju A, Pendela V S, Hai O.Cardiogenic Shock StatPearls Publishing; 2022. Accessed August 20, 2022, at:http://www.ncbi.nlm.nih.gov/books/NBK482255/ - PubMed
    1. PIBD-VTE Group ; PIBD-SETQuality Consortium . Aardoom M A, Klomberg R CW, Kemos P. The incidence and characteristics of venous thromboembolisms in paediatric-onset inflammatory bowel disease: a prospective international cohort study based on the PIBD-SETQuality Safety Registry. J Crohn's Colitis. 2022;16(05):695–707. - PMC - PubMed
    1. McKie K, McLoughlin R J, Hirsh M P, Cleary M A, Aidlen J T. Risk factors for venous thromboembolism in children and young adults with inflammatory bowel disease. J Surg Res. 2019;243:173–179. - PubMed
    1. Egberg M D, Galanko J A, Barnes E L, Kappelman M D. Thrombotic and infectious risks of parenteral nutrition in hospitalized pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2019;25(03):601–609. - PMC - PubMed
    1. Diamond C E, Hennessey C, Meldau J. Catheter-related venous thrombosis in hospitalized pediatric patients with inflammatory bowel disease: incidence, characteristics, and role of anticoagulant thromboprophylaxis with enoxaparin. J Pediatr. 2018;198:53–59. - PubMed